iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation

Insight Molecular Diagnostics (Nasdaq: IMDX) announced management will attend investor conferences during JPM Week and BTIG Snowbird in winter 2026.

Rhea-AI Summary

Insight Molecular Diagnostics (Nasdaq: IMDX) announced management will attend investor conferences during JPM Week and BTIG Snowbird in winter 2026. Key events: LifeSci Advisors 15th Annual Corporate Access Event (one-on-one meetings, Jan 12, The Beacon Grand, San Francisco), additional JPM Week investor meetings (one-on-one, Jan 12–14, San Francisco), and BTIG 13th Annual Snowbird (one-on-one meetings and skiing, Feb 9–11, Cliff Lodge, Snowbird, Utah). The company provided contact instructions for scheduling in-person meetings via LifeSci Partners or BTIG sales representatives.

Market Context

This announcement centers on IMDX’s investor-relations visibility, detailing participation in JPM We...

Analysis

This announcement centers on IMDX’s investor-relations visibility, detailing participation in JPM Week and BTIG’s February conference, with one‑on‑one meetings scheduled from January 12–14, 2026 and February 9–11. In recent months, the company has highlighted progress toward GraftAssureDx submission and commercialization, alongside modest but growing revenue. Investors may watch for future updates that pair this outreach with concrete regulatory, commercial, or financial milestones to assess execution against the 2026 launch plans.

Key Figures

LifeSci corporate access year: 15th Annual BTIG conference year: 13th Annual JPM Healthcare Conference year: 44th Annual +3 more

LifeSci corporate access year

15th Annual

LifeSci Advisors Corporate Access Event

BTIG conference year

13th Annual

BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

JPM Healthcare Conference year

44th Annual

Week of J.P. Morgan Healthcare Conference

LifeSci event date

January 12, 2026

LifeSci Advisors Corporate Access Event in San Francisco

JPM Week meetings window

January 12–14, 2026

Additional JPM Week investor meetings in San Francisco

BTIG conference dates

February 9–11

BTIG Snowbird MedTech and Diagnostics conference in Utah

Historical Context

5 past events · Latest: Jan 06

5 events

1. Jan 06

   Leadership appointment

   24h Move

   -1.1%

   Hired VP Medical Affairs to support transplant assay commercialization.

2. Jan 05

   Clinical/regulatory update

   24h Move

   +4.3%

   Reported GraftAssureDx de novo work ~95% complete and broad site engagement.

3. Nov 10

   Earnings and pipeline

   24h Move

   +9.0%

   Q3 2025 results with GraftAssureDx submission plans and registry build-out.

4. Nov 03

   Earnings pre-announcement

   24h Move

   +1.8%

   Set date for Q3 2025 results and highlighted upcoming investor conference.

5. Oct 13

   Leadership appointment

   24h Move

   +4.6%

   Named VP Marketing to drive 2026 commercial launch for GraftAssure family.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NASHVILLE, Tenn., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced members of its management team will participate in the following investor conferences this winter, which will include hosting meetings around the annual J.P. Morgan Healthcare Conference.

LifeSci Advisors 15^th Annual Corporate Access Event
Date: Monday, January 12^th
Location: The Beacon Grand, San Francisco, Calif.
Format: One-on-one meetings with management

Additional “JPM Week” Investor Meetings
Date: Monday, January 12^th through Wednesday, January 14^th
Location: San Francisco, Calif.
Format: One-on-one meetings with management

BTIG 13th Annual Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Date: February 9^{th –} 11^th
Location: Cliff Lodge, Snowbird, Utah
Format: One-on-one meetings and skiing with management

To request an in-person meeting with management on Monday, January 12^th, during the week of the 44^th Annual J.P. Morgan Healthcare Conference, either register at LifeSci Partners Corporate Access Event 2026 or contact our LifeSci Partners representatives Alexandra Grossman (alex@lifesciadvisors.com). For meetings at the BTIG conference, please contact your sales representative at BTIG.

About Insight Molecular Diagnostics, Inc.

Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.Insight Molecular Diagnostics.com/ for more information.

Investor Contact:
Doug Farrell
LifeSci Advisors LLC
dfarrell@lifesciadvisors.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Insight Molecular Diagnostics (IMDX) meet investors during JPM Week 2026?

Management will hold one-on-one investor meetings Jan 12–14, 2026 in San Francisco.

How can investors request an in-person meeting with IMDX management on Jan 12, 2026?

Register for the LifeSci Advisors Corporate Access Event or contact Alexandra Grossman at alex@lifesciadvisors.com to request a meeting.

What are the dates and location for IMDX at the BTIG Snowbird conference?

IMDX management will attend BTIG Snowbird Feb 9–11, 2026 at Cliff Lodge in Snowbird, Utah for one-on-one meetings.

What meeting formats will IMDX use at the LifeSci Advisors and BTIG events?

Both events feature one-on-one meetings with management; BTIG also notes informal skiing activities with management.

Who should IMDX investors contact for BTIG Snowbird meeting requests?

Investors should contact their BTIG sales representative to arrange meetings at the Snowbird conference.